Durvalumab Becomes Newest Immunotherapy Approved for Advanced Bladder Cancer May 5, 2017December 14, 2022 Arthur N. Brodsky, PhD
FDA approves Keytruda combo for first-line lung cancer treatment May 12, 2017December 14, 2022 Arthur N. Brodsky, PhD
Immunotherapy Makes History with Latest Cancer Approval May 23, 2017December 14, 2022 Arthur N. Brodsky, PhD
ASCO17: Exploring the Past, Present, and Future of Immunotherapy June 1, 2017December 14, 2022 Arthur N. Brodsky, PhD